BioSpace News Archive

BioCapital

QIAGEN Launches New QIAseq FastSelect Solutions to Accelerate RNA-seq

Highlighting broad portfolio of universal NGS solutions at American Society for Human Genetics (ASHG) 2019 genomic research conference

October 14, 2019
·
1 min read
Business

Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019

The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter 2019 financial and operating results.

October 14, 2019
·
1 min read
Business

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation - Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas

HCSC coverage decision adds more than 16 million covered lives for Eversense CGM

October 14, 2019
·
5 min read
Business

NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results

The Company will release its third quarter 2019 earnings results on Wednesday, October 30, 2019 after the close of the market.

October 14, 2019
·
2 min read
Deals

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 - Oct. 14, 2019

LabCorp® announced that its Zero Coupon Convertible Subordinated Notes due 2021 may be converted as set forth below.

October 14, 2019
·
3 min read
FDA

Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

The product is manufactured at Akorn’s Amityville, New York manufacturing facility.

October 14, 2019
·
1 min read
Business

Brown Gibbons Lang & Company Joins the DxPx Conference at MEDICA as an Alliance Partner

The DxPx Conference is an event for emerging growth companies, global industry participants, and investors in diagnostics and research tools; it is designed to facilitate licensing, financing, co-development and M&A opportunities.

October 14, 2019
·
4 min read
Drug Development

Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15

At 8:30 AM Eastern Time the Company will host a conference call to discuss the results of the study with the investment community.

October 14, 2019
·
2 min read
Clinigen Launches Managed Access Program for Progenics Pharmaceuticals for AZEDRA® Outside the US

AZEDRA is not approved for use outside of the United States.

October 14, 2019
·
3 min read
Pharm Country

Redesign Science Raises $2M in Seed Funding to Advance Early-Stage Drug Discovery

Investment to support scaling of technology platform and advance multiple biotech partnerships

October 14, 2019
·
2 min read